A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
Summary
Third Opinion Trial Synopsis:
Doctors are testing a new treatment called targeted therapy for a type of cancer called Smoldering Multiple Myeloma. The treatment involves using three drugs: Lenalidomide, Citarinostat (CC-96241), and PVX-410. The study is being done to see if this treatment can help people with Smoldering Multiple Myeloma.
Doctors are testing a new treatment called targeted therapy for a type of cancer called Smoldering Multiple Myeloma. The treatment involves using three drugs: Lenalidomide, Citarinostat (CC-96241), and PVX-410. The study is being done to see if this treatment can help people with Smoldering Multiple Myeloma.
*Third Opinion AI Generated Synopsis
Trial Summary
This research study is studying a targeted therapy as a possible treatment for Smoldering Multiple Myeloma. The following intervention will be involved in this study: Lenalidomide Citarinostat (CC-96241) PVX-410
This research study is studying a targeted therapy as a possible treatment for Smoldering Multiple Myeloma. The following intervention will be involved in this study: Lenalidomide Citarinostat (CC-96241) PVX-410
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: